Boerne Eyes on Main PLLC – Trademark Portfolio

Entity Type: 99

Boerne Eyes on Main PLLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include E M. The owner is based in Boerne, TX.

1365 S. Main

Boerne, TX 78006

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

E M
E M
Registered 2018

Trademark Classifications

Boerne Eyes on Main PLLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Boerne Eyes on Main PLLC have?

Boerne Eyes on Main PLLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Boerne Eyes on Main PLLC file in?

Boerne Eyes on Main PLLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are Boerne Eyes on Main PLLC's most well-known trademarks?

Boerne Eyes on Main PLLC's registered trademark portfolio includes well-known marks such as E M. These are among 1 currently registered trademark in the portfolio.

What is Boerne Eyes on Main PLLC's trademark registration success rate?

Boerne Eyes on Main PLLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.